Scientists from around the world will gather to discuss the liver sinusoid, a specialized type of blood capillary found in the liver, and its role in ageing, regeneration, and disease
From May 23 to 26, 2026, Tarragona will welcome researchers and professionals specializing in liver sinusoidal biology. Under the theme of understanding the crucial role of the liver sinusoid in hepatic function, disease progression, ageing, and tissue regeneration, The Liver Sinusoid Meeting 2026 will mark the 23rd edition of this prestigious event. It will also coincide with the 50th anniversary of its organizing body, the International Society for Hepatic Sinusoidal Research (ISHSR). This scientific meeting aims to explore the complexity of liver microcirculation, immune regulation, and cellular interactions within the sinusoidal space. The program will highlight the latest advances in sinusoidal endothelial cell biology, liver immunology, fibrosis, and innovative therapeutic approaches.
Attendees will have the opportunity to learn from a distinguished group of international experts who will lead discussions on current challenges and future directions in liver sinusoid research. In addition to scientific sessions, the congress will feature a cultural program, including guided tours of Tarragona’s Roman heritage sites.
Registration and Abstract Submission
The Liver Sinusoid Meeting 2026 opens its registration period from October 1 to December 31, both days this year 2025. The congress is also open to a call for research and there is time to present it until December 31, 2025.
Among those present in the organizational committee, is the head of the area of Metabolic Diseases and Nutrition of Institut d’Investigació Sanitària Pere Virgili, Sonia Fernández-Veledo, also responsible for the research group in ‘Diabetes and Associated Metabolic Diseases’ (DIAMET).
The scientific meeting receives the institutional support of: Departament de Recerca i Universitats de la Generalitat de Catalunya, Patronat Municipal de Turisme de Tarragona, Ajuntament de Tarragona, Centro de Investigación Biomédica en Red en el Área de Enfermedades Hepáticas y Digestivas and Instituto de Salud Carlos III.
Facebook 
Mail 
WhatsApp 
